亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

萊佛士制藥技術有限公司  

醫藥中間體和原料藥;有機催化劑;提供國際水準的綠色工藝開發、定制合成與生產等方面的服務

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:莫先生
  • 電話:0752-5538396
  • QQ:2634038916
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 452339-73-0
452339-73-0
單價 面議對比
詢價 暫無
發貨 廣東惠州市付款后3天內
品牌 RAFFLES
規格 1-10g;100g;500g;1kg;10kg
純度 ≥98%
貨期 1-2 周
過期 長期有效
更新 2016-08-15 10:26
 
詳細信息
 
中文名稱: 2-惡唑烷酮, 5-(2,2-二甲基-4H-1,3-苯并二氧-6-YL), (5R)-
中文同義詞: 2-惡唑烷酮, 5-(2,2-二甲基-4H-1,3-苯并二氧-6-YL), (5R)-;(R)-5-(2,2-DIMETHYL-4H-BENZO[D][1,3]DIOXIN-6-YL)OXAZOLIDIN-2-ONE;(5R)-5-(2,2-二甲基-4H-1,3-苯并二氧雜環己-6-基)-1,3-惡唑烷-2-酮
英文名稱: 2-Oxazolidinone, 5-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl)-, (5R)-
英文同義詞: 2-Oxazolidinone, 5-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl)-, (5R)-;(5R)-2-Oxazolidinone, 5-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl);(5R)-5-(2,2-DiMethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one;(R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one
CAS號: 452339-73-0
分子式: C13H15NO4
分子量: 249.2625
EINECS號: -0
相關類別:  
Mol文件: 452339-73-0.mol
2-惡唑烷酮, 5-(2,2-二甲基-4H-1,3-苯并二氧-6-YL), (5R)-
©2025 萊佛士制藥技術有限公司 版權所有   技術支持:化工網   訪問量:2757  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |